TY - JOUR
T1 - Diagnosis and Treatment of Tuberculosis in the Private Sector, Vietnam
AU - Hoa, N.B.
AU - Cobelens, F.G.J.
AU - Sy, D.N.
AU - Nhung, N.V.
AU - Borgdorff, M.W.
AU - Tiemersma, E.W.
PY - 2011
Y1 - 2011
N2 - To the Editor: In many countries, the private sector (practitioners not employed by government and nongovernment institutions, e.g., hospitals, pharmacies) is a major source of care, even for poor persons, and the area where services for the public are widely available (1,2). However, little information is available from high-incidence countries about the role of the private sector in tuberculosis (TB) detection and treatment (3). In Vietnam, ≤40% of all TB cases in Ho Chi Minh City (the largest city in Vietnam and with the highest rate of economic growth in the country) were estimated to be treated in the private sector (4), and half of all patients with a diagnosis of TB in the public sector (National Tuberculosis Program [NTP]) in Ho Chi Minh City initially sought help in the private sector (5). However, this estimate does not reflect private care in the entire country
AB - To the Editor: In many countries, the private sector (practitioners not employed by government and nongovernment institutions, e.g., hospitals, pharmacies) is a major source of care, even for poor persons, and the area where services for the public are widely available (1,2). However, little information is available from high-incidence countries about the role of the private sector in tuberculosis (TB) detection and treatment (3). In Vietnam, ≤40% of all TB cases in Ho Chi Minh City (the largest city in Vietnam and with the highest rate of economic growth in the country) were estimated to be treated in the private sector (4), and half of all patients with a diagnosis of TB in the public sector (National Tuberculosis Program [NTP]) in Ho Chi Minh City initially sought help in the private sector (5). However, this estimate does not reflect private care in the entire country
U2 - https://doi.org/10.3201/eid1703.101468
DO - https://doi.org/10.3201/eid1703.101468
M3 - Article
C2 - 21392464
SN - 1080-6040
VL - 17
SP - 562
EP - 564
JO - Emerging infectious diseases
JF - Emerging infectious diseases
IS - 3
ER -